These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10414432)

  • 1. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF.
    Jones DN; Kortekaas R; Hatcher PD; Middlemiss DN; White A; Hagan JJ
    Eur J Pharmacol; 1999 Jun; 373(2-3):141-5. PubMed ID: 10414432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L; Liu Z; Huang M; Zhang Z
    J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
    Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
    J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
    Bonk I; Rühmann A
    Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioural effects of corticotropin-releasing factor-related peptides in rats.
    Jones DN; Kortekaas R; Slade PD; Middlemiss DN; Hagan JJ
    Psychopharmacology (Berl); 1998 Jul; 138(2):124-32. PubMed ID: 9718281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat.
    Rivier C; Rivier J; Lee S
    Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
    Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin affects food intake via CRF-receptor-mediated pathways.
    Gardner JD; Rothwell NJ; Luheshi GN
    Nat Neurosci; 1998 Jun; 1(2):103. PubMed ID: 10195123
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
    J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
    Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
    Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
    Lu L; Liu D; Ceng X
    Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.
    Macey DJ; Koob GF; Markou A
    Brain Res; 2000 Jun; 866(1-2):82-91. PubMed ID: 10825483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
    Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
    J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL; Anderson DL; McGlone JJ
    Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.
    Gulyas J; Rivier C; Perrin M; Koerber SC; Sutton S; Corrigan A; Lahrichi SL; Craig AG; Vale W; Rivier J
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10575-9. PubMed ID: 7479843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.